Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naodesheng soft capsule vs Naodesheng tablet for post-stroke sequelae
CTR20131528Phase 2Active
- Sponsor
- Anhui Antai Pharmaceutical Biotechnology
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Naodesheng in sequela, cerebral arteriosclerosis, ischemic stroke, intracerebral hemorrhage (ICH), sponsored by Anhui Antai Pharmaceutical Biotechnology. Started Nov 2013; status: active.
02
Drugs
Naodesheng
03
Conditions
sequelacerebral arteriosclerosisischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on CTR20131528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131528.